BMAL1 Proteostasis, Circadian Dysfunction, and Ferroptotic Vulnerability in Osteoporosis: Current Evidence and Experimental Priorities

Jun 9, 2026Calcified tissue international

Disrupted Daily Protein Control and Cell Death Risk Linked to Bone Loss: Current Findings and Research Needs

AI simplified

Abstract

Current evidence supports that ferroptosis is directly established in osteoblasts and osteocytes across several contexts related to osteoporosis.

  • Circadian regulation in bone involves more than just the abundance of BMAL1 and should be understood within a larger biological clock network.
  • Ferroptosis, a type of cell death, is implicated in osteoblasts and osteocytes in various osteoporosis-related conditions, including postmenopausal and diabetic scenarios.
  • BMAL1 plays a crucial role in the differentiation of skeletal cells and their ability to adapt to stress, although its degradation and related processes in bone cells have not been shown yet.
  • Although clockophagy is not an established pathway in skeletal cells, the existing literature provides a framework for exploring the potential pathogenic role of BMAL1 proteostasis in osteoporosis.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • šŸ“š7 fresh studies
  • šŸ“plain-language summaries
  • āœ…direct links to original studies
  • šŸ…top journal indicators
  • šŸ“…weekly delivery
  • šŸ§˜ā€ā™‚ļøalways free